Efficacy and safety of larotrectinib as first-line treatment for adult patients with TRK fusion cancer
Publication/Presentation Date
3-2025
Volume
10
Issue
3
Published In/Presented At
Disciplines
Medicine and Health Sciences
Department(s)
Hematology-Medical Oncology Division
Document Type
Article
COinS